Viewing Study NCT03158935

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:22 PM
Ignite Modification Date: 2026-02-20 @ 6:05 PM
Study NCT ID: NCT03158935
Status: COMPLETED
Last Update Posted: 2020-08-14
First Post: 2017-05-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial
Sponsor: University Health Network, Toronto
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Ovarian Cancer View
None Malignant Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adoptive cell therapy View
None melanoma View
None ovarian View
None cyclophosphamide View
None fludarabine View
None tumor-infiltrating lymphocytes (TILs) View
None pembrolizumab View
None interleukin-2 View
None anti-PD-1 View
None immune checkpoint View